Tanzania to subject Madagascar Covid-19 medicine to clinical trials

By The Citizen |

The drink is derived from artemisia — a plant with proven efficacy in malaria treatment — and other indigenous herbs. PHOTO | THE CITIZEN

Tanzania will not administer the medicine which was yesterday collected from Madagascar on patients until a clinical trial has been carried out by the National Institute for Medical Research (NIMR).

Speaking today at a news conference in Dar es Salaam, Tanzania’s foreign affairs minister Prof Palamagamba Kabudi who led the team to Antananarivo said the task at hand starting from today is to research and analyse the medicine before putting it to use.

“I want to make it clear among Tanzanians that we haven’t come with medicine to distribute among the citizens, rather we have brought a consignment for research and analysis,” said Prof Kabudi

According to him, the eight red colored boxes consists medicine produced for prevention purposes while the four green colored boxes consist with the medicine for use by those confirmed to have contracted the disease.

“They didn’t provide us the medicine that is ready for use. Nobody in the delegation tested the medicine, it was only me with my Madagascar counterpart just as the demonstration of our respect for the donation,” he said.

Read more of this report

(Visited 66 times, 1 visits today)
About Cholo Brooks 13184 Articles
Joel Cholo Brooks is a Liberian journalist who previously worked for several international news outlets including the BBC African Service. He is the CEO of the Global News Network which publishes two local weeklies, The Star and The GNN-Liberia Newspapers. He is a member of the Press Union Of Liberia (PUL) since 1986, and several other international organizations of journalists, and is currently contributing to the South Africa Broadcasting Corporation as Liberia Correspondent.